These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biological Role and Therapeutic Targeting of TGF-β Seystahl K; Papachristodoulou A; Burghardt I; Schneider H; Hasenbach K; Janicot M; Roth P; Weller M Mol Cancer Ther; 2017 Jun; 16(6):1177-1186. PubMed ID: 28377490 [TBL] [Abstract][Full Text] [Related]
3. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas. Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494 [TBL] [Abstract][Full Text] [Related]
4. Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors. Roy LO; Poirier MB; Fortin D Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642484 [TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer. Hazelbag S; Kenter GG; Gorter A; Fleuren GJ Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352 [TBL] [Abstract][Full Text] [Related]
6. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway. Silginer M; Burghardt I; Gramatzki D; Bunse L; Leske H; Rushing EJ; Hao N; Platten M; Weller M; Roth P Oncogene; 2016 Jun; 35(25):3260-71. PubMed ID: 26500056 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894 [TBL] [Abstract][Full Text] [Related]
8. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells. Gramatzki D; Pantazis G; Schittenhelm J; Tabatabai G; Köhle C; Wick W; Schwarz M; Weller M; Tritschler I Oncogene; 2009 Jul; 28(28):2593-605. PubMed ID: 19465936 [TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma differentially regulates TGF-beta1 and TGF-beta2 expression in human retinal pigment epithelial cells through JAK-STAT pathway. Nagineni CN; Cherukuri KS; Kutty V; Detrick B; Hooks JJ J Cell Physiol; 2007 Jan; 210(1):192-200. PubMed ID: 17013806 [TBL] [Abstract][Full Text] [Related]
11. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
12. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway. He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor. Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone. Masi L; Malentacchi C; Campanacci D; Franchi A Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts. Ylä-Outinen H; Aaltonen V; Björkstrand AS; Hirvonen O; Lakkakorpi J; Vähä-Kreula M; Laato M; Peltonen J J Invest Dermatol; 1998 Mar; 110(3):232-7. PubMed ID: 9506441 [TBL] [Abstract][Full Text] [Related]
16. NF-κB induces miR-148a to sustain TGF-β/Smad signaling activation in glioblastoma. Wang H; Pan JQ; Luo L; Ning XJ; Ye ZP; Yu Z; Li WS Mol Cancer; 2015 Feb; 14():2. PubMed ID: 25971746 [TBL] [Abstract][Full Text] [Related]
17. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors. Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300 [TBL] [Abstract][Full Text] [Related]
18. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma. Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869 [TBL] [Abstract][Full Text] [Related]
19. Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma. Kawataki T; Naganuma H; Sasaki A; Yoshikawa H; Tasaka K; Nukui H Neuropathology; 2000 Sep; 20(3):161-9. PubMed ID: 11132930 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. Bossé Y; Thompson C; Stankova J; Rola-Pleszczynski M Am J Respir Cell Mol Biol; 2006 Jun; 34(6):746-53. PubMed ID: 16439802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]